TOKYO (Reuters) – Japan is taking an aggressive step to seize enough coronavirus vaccine to inoculate its population four times, a pressure that the government hopes to instill confidence that it can host a delayed Olympic Games next year. FILE PHOTO: People in traditional costume kimonos, wearing protective masks as …
Read More »Gilead: FDA could extend the use of remdesivir despite mixed data
(Reuters) – The U.S. Food and Drug Administration was able to update its emergency use authorization for Gilead Sciences Inc’s (GILD.O) brakesivir of drugs to admit patients admitted to hospital with moderate COVID-19, despite mixed test results, the company’s top study said on Friday. FILE PHOTO: An ampoule of Ebola …
Read More »China approves human tests for coronavirus vaccine grown in insect cells
PHILO PHOTO: A woman holding a small bottle labeled “Vaccine COVID-19” and a medical syringe in this illustration April 10, 2020. REUTERS / Dado Ruvic / Illustration BEIJING (Reuters) – China has approved human tests for a potential coronavirus vaccine that is cultured inside insect cells, local government in the …
Read More »Exclusive: Approximately one-fifth of Pfizer subscribers, BioNTech COVID-19 vaccine study are Black or Latino
CHICAGO / NEW YORK (Reuters) – Approximately one-fifth of the 11,000 people enrolled in a 30,000-volunteer U.S. trial of a Pfizer COVID-19 vaccine (PFE.N) and German partner BioNTech (22UAy.F) are Black as Latino, groups among the hardest hit by the coronavirus virus pandemic, said a top Pfizer executive. PHILO PHOTO: …
Read More »Moderna says that more than 40% of participants sign up for COVID-19 vaccine test
FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against coronavirus (COVID-19), in Cambridge, Massachusetts, USA, May 18, 2020. REUTERS / Brian Snyder (Reuters) – Drug Developer Moderna Inc (MRNA.O) on Friday said it has so far enrolled 13,194 participants in the ongoing 30,000-volunteer …
Read More »